Denosumab Versus Risedronate: Efficacy And Safety In Postmenopausal Women Suboptimally Adherent To Alendronate Therapy In A Randomized Open-Label Study
AuthID
P-009-731
P-009-731
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service